Thanks for highlighting our work!

Mind the gap! New paper (and company) from The Sellers Lab and Broad Institute systematically studies growth pathway *activation* in cancer, with therapeutic intent. While already established conceptually, this systems effort to target the third rail of cancer medicine will be

Great article featuring my PhD work and our recent publication by Lei Lei Wu Endpoints News

Read this week's Cancer Discovery #ResearchWatch: Hyperactivation of Oncogenic Pathways Hinders #CancerCell Survival, summarizing the work of Liang Chang, The Sellers Lab et al. bit.ly/3rPz50G Broad Institute Dana-Farber Harvard Medical School